Jun Gi Hwang (Jun-Gi Hwang, JunGi Hwang)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 18

Top Topics

Computed Tomography

Glycemic Control

Top Venues

Translational and clinical pharmacology

British journal of clinical pharmacology

Expert opinion on biological therapy

Diabetes, obesity & metabolism

This page only lists publications with an associated author ORCID identifier.

Publications

Kyung-Sang Yu, Hyunwook Ryu, Dongseong Shin, Min-Kyu Park, Jun Gi Hwang, Seol Ju Moon, Min Gul Kim, Edward C Keystone, Josef S Smolen, SungHyun Kim, YunJu Bae, DaBee Jeon, JiYoung Jang, GoEun Yang, JiHun Bae, JaeYong Lee, Gerd R Burmester
Pharmacokinetics and safety of candidate tocilizumab biosimilar CT-P47 administered by auto-injector or pre-filled syringe: a randomized, open‑label, single-dose phase I study. Expert opinion on biological therapy 24 (7) (2024)
Kyung-Sang Yu, Hyunwook Ryu, Dongseong Shin, Min-Kyu Park, Jun Gi Hwang, Seol Ju Moon, Min Gul Kim, Edward C Keystone, Josef S Smolen, SungHyun Kim, YunJu Bae, DaBee Jeon, JiYoung Jang, GoEun Yang, JiHun Bae, JaeYong Lee, Gerd R Burmester
Pharmacokinetics and safety of candidate tocilizumab biosimilar CT-P47 administered by auto-injector or pre-filled syringe: a randomized, open‑label, single-dose phase I study. Expert opinion on biological therapy 24 (7) (2024)
Sae Im Jeong, Mu Seong Ban, Jun Gi Hwang, Min-Kyu Park, Soo Lim, Sejoong Kim, Soon Kil Kwon, Yoonjin Kim, Jae Min Cho, Jae Jin Na, Wan Huh, Jae-Young Chung
The effect of renal function on the pharmacokinetics and pharmacodynamics of enavogliflozin, a potent and selective sodium-glucose cotransporter-2 inhibitor, in type 2 diabetes. Diabetes, obesity & metabolism (2024)
Kyung-Sang Yu, Hyunwook Ryu, Dongseong Shin, Min-Kyu Park, Jun Gi Hwang, Seol Ju Moon, Min Gul Kim, Edward C Keystone, Josef S Smolen, SungHyun Kim, YunJu Bae, DaBee Jeon, JiYoung Jang, GoEun Yang, JiHun Bae, JaeYong Lee, Gerd R Burmester
Pharmacokinetics and safety of candidate tocilizumab biosimilar CT-P47 administered by auto-injector or pre-filled syringe: a randomized, open‑label, single-dose phase I study. Expert opinion on biological therapy 24 (7) (2024)
Kyung-Sang Yu, Hyunwook Ryu, Dongseong Shin, Min-Kyu Park, Jun Gi Hwang, Seol Ju Moon, Min Gul Kim, Edward C Keystone, Josef S Smolen, SungHyun Kim, YunJu Bae, DaBee Jeon, JiYoung Jang, GoEun Yang, JiHun Bae, JaeYong Lee, Gerd R Burmester
Pharmacokinetics and safety of candidate tocilizumab biosimilar CT-P47 administered by auto-injector or pre-filled syringe: a randomized, open‑label, single-dose phase I study. Expert opinion on biological therapy (2024)
Sae Im Jeong, Mu Seong Ban, Jun Gi Hwang, Min-Kyu Park, Soo Lim, Sejoong Kim, Soon Kil Kwon, Yoonjin Kim, Jae Min Cho, Jae Jin Na, Wan Huh, Jae-Young Chung
The effect of renal function on the pharmacokinetics and pharmacodynamics of enavogliflozin, a potent and selective sodium-glucose cotransporter-2 inhibitor, in type 2 diabetes. Diabetes, obesity & metabolism 26 (7) (2024)
Se Rin Park, Jun Gi Hwang, Sae Im Jeong, Young-Sim Choi, Hyo Jin Min, Hye Yun Kim, Bong-Hoi Choi, Min-Kyu Park
Comparison of the pharmacokinetic characteristics and bioequivalence between two nanosuspension formulations of megestrol acetate in healthy Korean male subjects. Translational and clinical pharmacology 32 (1) (2024)
Se Rin Park, Jun Gi Hwang, Sae Im Jeong, Young-Sim Choi, Hyo Jin Min, Hye Yun Kim, Bong-Hoi Choi, Min-Kyu Park
Comparison of the pharmacokinetic characteristics and bioequivalence between two nanosuspension formulations of megestrol acetate in healthy Korean male subjects. Translational and clinical pharmacology 32 (1) (2024)
Jun Gi Hwang, Sae Im Jeong, Yu-Kyong Kim, Yujin Lee, Sang Chun Ji, Seung Hwan Lee, Min-Kyu Park
Common ABCB1 SNP, C3435T could affect systemic exposure of dapagliflozin in healthy subject. Translational and clinical pharmacology 30 (4) (2022)
Sae Im Jeong, Yun Kim, Jae Jin Nah, Wan Huh, In-Jin Jang, Jun Gi Hwang, Seung Hwan Lee
Pharmacokinetic and pharmacodynamic interaction of DWP16001, a sodium-glucose cotransporter 2 inhibitor, with gemigliptin and metformin in healthy adults. British journal of clinical pharmacology (2022)
Sae Im Jeong, Yun Kim, Jae Jin Nah, Wan Huh, In-Jin Jang, Jun Gi Hwang, Seung Hwan Lee
Pharmacokinetic and Pharmacodynamic Interaction of DWP16001, an SGLT2 Inhibitor, with Gemigliptin and Metformin in Healthy Adults. British journal of clinical pharmacology (2022)
Jun Gi Hwang, Sae Im Jeong, Yu-Kyong Kim, Yujin Lee, Sang Chun Ji, Seung Hwan Lee, Min-Kyu Park
Common ABCB1 SNP, C3435T could affect systemic exposure of dapagliflozin in healthy subject. Translational and clinical pharmacology 30 (4) (2022)
Byungwook Kim, Ki Young Huh, Jun Gi Hwang, Jae Jin Nah, Wan Huh, Jae Min Cho, In-Jin Jang, Kyung-Sang Yu, Yun Kim, Seung Hwan Lee
Pharmacokinetic and Pharmacodynamic Interaction Between DWP16001, an SGLT2 Inhibitor, and Metformin in Healthy Subjects. British journal of clinical pharmacology (2022)
Jun Gi Hwang, Seung Hwan Lee, Wan Huh, Jumi Han, Jaeseong Oh, In-Jin Jang, Kyung-Sang Yu
Dose-dependent glucosuria of DWP16001, a novel selective sodium-glucose cotransporter-2 inhibitor, in healthy subjects. British journal of clinical pharmacology 88 (9) (2022)
Yu-Kyong Kim, Jun Gi Hwang, Min-Kyu Park
No Relevant Pharmacokinetic Drug-Drug Interaction Between the Sodium-Glucose Co-Transporter-2 Inhibitor Empagliflozin and Lobeglitazone, a Peroxisome Proliferator-Activated Receptor-γ Agonist, in Healthy Subjects. Drug design, development and therapy 15 (2021)
Ki Young Huh, Jun Gi Hwang, Wonjung Shin, SeungJae Baek, JaeDuk Choi, Nora Lee, Young Min Cho, Howard Lee
A double-blind, placebo-controlled, single-ascending dose study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of HM15136, a novel long-acting glucagon analogue, in healthy subjects. Diabetes, obesity & metabolism (2021)
Jun Gi Hwang, Seung Hwan Lee
Editorial: acid suppression with potassium-competitive acid blockers-dismissing genotype concerns. Authors' reply. Alimentary pharmacology & therapeutics 53 (1) (2021)
Jun Gi Hwang, Inseung Jeon, Sun Ae Park, Areum Lee, Kyung-Sang Yu, In-Jin Jang, SeungHwan Lee
Pharmacodynamics and pharmacokinetics of DWP14012 (fexuprazan) in healthy subjects with different ethnicities. Alimentary pharmacology & therapeutics 52 (11-12) (2020)